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ABSTRACT
Infection by (re-)emerging RNA arboviruses including Chikungunya virus (CHIKV) and Mayaro virus primarily cause acute
febrile disease and transient polyarthralgia. However, in a significant subset of infected individuals, debilitating arthralgia
persists for weeks over months up to years. The underlying immunopathogenesis of chronification of arthralgia upon
primary RNA-viral infection remains unclear. Here, we analysed cell-intrinsic responses to ex vivo arthritogenic
alphaviral infection of primary human synovial fibroblasts isolated from knee joints, one the most affected joint types
during acute and chronic CHIKV disease. Synovial fibroblasts were susceptible and permissive to alphaviral infection.
Base-line and exogenously added type I interferon (IFN) partially and potently restricted infection, respectively. RNA-
seq revealed a CHIKV infection-induced transcriptional profile that comprised upregulation of expression of several
hundred IFN-stimulated and arthralgia-mediating genes. Single-cell virus-inclusive RNA-seq uncovered a fine-tuned
switch from induction to repression of cell-intrinsic immune responses depending on the abundance of viral RNA in
an individual cell. Specifically, responses were most pronounced in cells displaying low-to-intermediate amounts of
viral RNA and absence of virus-encoded, fluorescent reporter protein expression, arguing for efficient counteraction
of innate immunity in cells expressing viral antagonists at sufficient quantities. In summary, cell-intrinsic sensing of
viral RNA that potentially persists or replicates at low levels in synovial fibroblasts and other target cell types in vivo
may contribute to the chronic arthralgia induced by alphaviral infections. Our findings might advance our
understanding of the immunopathophysiology of long-term pathogenesis of RNA-viral infections.
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Introduction
Chikungunya virus (CHIKV) and Mayaro virus
(MAYV) are arthritogenic alphaviruses of the Togavir-
idae family, which are transmitted byAedes sp.mosqui-
toes and circulate both in urban cycles between vectors
and humans, and in sylvatic cycles [1,2]. Hallmarks of
the typically relatively short acute disease are febrile ill-
ness, rashes, and excruciating pain in multiple joints.
Relapsing-remitting arthralgia persists in a subgroup
of patients for months to years [3]. The underlying
immunopathophysiology of the chronic symptoms
remains largely unclear, but appears to associate with
circulating IL-6 [4] and IL-12 [5]. Interestingly, a
much-discussed hypothesis suggests that it may involve
persistence of viral RNA in synovial macrophages,
muscle cells, and fibroblasts in vivo [5–7].
Multiple studies on alphaviruses in immortalized
model cell lines and in vivo in immunodeficient mice
have provided valuable information on key aspects of
CHIKV andMAYV tropism and replication, including
host factors for entry and replication [8,9], the impact
of mutations in the viral glycoproteins on cell entry
[10], and cellular restriction factors acting against
CHIKV and other alphaviruses [11]. Additionally,
studies investigating immune responses to infection
have demonstrated that CHIKV nsP2 counteracts
host immunity by blocking nuclear translocation of
STAT1 [12] and inducing a host transcriptional shut-
down [13]. Sensing of infection-induced DNA leakage,
as described for RNA viruses before [14], is efficiently
subverted by CHIKV through its nonstructural pro-
teins [15]. However, the relevance and consequence
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of these and potentially additional immunity-subvert-
ing mechanisms in infected patients remain unclear.
In vivo studies in mice, though recapitulating both
innate and adaptive immune responses, require a
type I interferon (IFN)-deficient background, neglect-
ing the impact of type I IFN-mediated antiviral
responses [16]. Type I IFN induced in and acting on
nonhematopoietic cells appears to be essential for the
control and early clearance of CHIKV in vivo [17].
Therefore, these models do not fully recapitulate the
cellular environment of human primary cells and tis-
sues that are targeted by CHIKV and MAYV in vivo.
Primary human cells have been used sporadically for
ex vivo infection [18,19], but their unique properties
in terms of susceptibility to infection and cell-intrinsic
responses remain poorly investigated. Synovial fibro-
blasts have been described to be a key driver for rheu-
matoid arthritis by facilitating proinflammatory
processes and stimulating the degradation of cartilage
[20], and it is plausible that they contribute to
CHIKV spread and pathogenesis in vivo. Here, we per-
form an in depth-characterization of primary human
synovial fibroblasts extracted from human knee joint
biopsies as an ex vivo model of CHIKV and MAYV
infection. We demonstrate that synovial fibroblasts
are susceptible and permissive to infection by both
arthritogenic alphaviruses. Using bulk and single-cell
approaches, we identified cell-intrinsic immune
responses that were most pronounced in non-produc-
tively infected cells, suggestive of effective viral antag-




Human osteosarcoma U2OS cells (a kind gift from
T. Stradal, Hanover), human HEK293 T cells (a kind
gift from J. Bohne, Hanover), human foreskin fibro-
blast HFF-1 cells (ATCC SCRC-1041), human
HL116 cells (a kind gift from Sandra Pellegrini, Insti-
tut Pasteur, France [21]), and hamster BHK-21 cells
(ATCC CCL-10) were grown in Dulbecco’s modified
Eagle’s medium – high glucose (DMEM, Sigma-
Aldrich D5671) supplemented with 10% heat-inacti-
vated fetal bovine serum (FBS, Sigma-Aldrich
F7524), 2 mM L-Glutamine (Gibco 25030081), and
100 units/ml penicillin–streptomycin (Gibco
11548876). HL116 cell received 1X HAT supplement
(Gibco 21060017) in addition.
Primary human fibroblasts were obtained from
synovial biopsies from knee joins fromdonors suffering
from osteoarthritis (osteroarthrosis synovial fibro-
blasts, OASF) or a non-arthritic background (healthy
donor synovial fibroblasts, HSF), purified, and cultured
as described before [22]. Mycoplasma testing was
routinely performed and negative in all primary
human cell cultures. After 2–4 passages of initial culti-
vation, cells were expanded and used for experiments in
high glucose DMEM supplemented with 20% FBS,
2 mM L-Glutamine, 100 units/ml penicillin–strepto-
mycin, 1% non-essential amino acids (Gibco
11140050), and 1% sodium pyruvate (Gibco
11360070). The CHIKV LR2006-OPY 5′GFP and
MAYV TRVL4675 5′GFP infectious clones expressing
EGFP under the control of a subgenomic promotor
(hereafter referred to as CHIKV and MAYV) have
been described previously [23,24]. Virus was produced
by in vitro-transcription of and subsequent electropora-
tion of RNA into BHK-21 cells. Virus-containing
supernatant was collected, passaged once on BHK-21
cells and viral titers were determined by titration on
HEK293T cells.
Infection, treatments, transfections
EGFP expression as surrogate for productive CHIKV or
MAYV infection was quantified on a BD FACSCalibur,
FACSLyric or Accuri C6. For neutralization assays,
virus-containing supernatants were pre-incubated for
one hour with anti-CHIKV E2 antibody C9 (Integral
Molecular C9, Lot INT MAB-003) at 1 µg/ml or with
recombinant MXRA8-Fc (a kind gift from
M. Diamond) at 150 ng/ml. Recombinant IFN-α2a
(Roferon L03AB04, Roche) and IFN-λ1 (Peprotech
300-02L) was used where indicated. Transfections were
performed using Lipofectamine2000 (Thermo Fisher
11668019) for plasmid DNA (pcDNA6 empty vector)
or 5′triphosphate dsRNA (InvivoGen tlrl-3prna).
Bulk RNA-Seq analysis
RNAwas extracted using the PromegaMaxwell 16 with
LEV simplyRNA Tissue Kits (Promega AS1270). RNA
quality was assessed using the Agilent Bioanalyzer and
appropriate samples were used for NGS library prep-
aration with the NEBNext Ultra II Directional RNA
kit (NEB E7760) and sequenced with 50 bp paired-
end reads and 30 mio reads per sample on the Illumina
HiSeq 2500. Data were analysed with CLC Genomics
Workbench 12 (QIAGEN) by mapping the human
reads onto the hg19 reference genome scaffold
(GCA_000001405.28). Unmapped reads not matching
the human genome were subsequently mapped onto
the CHIKV genome LR2006_OPY (DQ443544.2). For
HSF, infection and analysis were performed similarly,
but RNA was extracted with the Direct-Zol RNAMini-
Prep Kit (Zymo Research R2051), NGS libraries were
prepared with the TruSeq stranded mRNA kit (Illu-
mina 20020594) and sequencing was performed on
the Illumina NextSeq500 with 65 mio reads per sample.
Biological process enrichment was analysed by Gene
Ontology [25].
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Single-Cell RNA-Seq analysis
Infected cells were trypsinized, debris was removed by
filtration, and the suspension was adjusted to a final
amount of ∼16,000 cells per lane to achieve the recov-
ery of 10,000 cells per donor after partitioning intoGel-
Beads in Emulsion (GEMs) according to the instruc-
tions for Chromium Next GEM Single Cell 3′ GEM,
Library & Gel Bead Kit v3.1 provided by the manufac-
turer (10X Genomics PN-1000121). Polyadenylated
mRNAs were tagged with unique 16 bp 10X barcodes
and the 10 bp Unique Molecular Identifiers (UMIs),
reverse transcribed and resulting cDNAs were bulk
amplified. After enzymatic fragmentation and size
selection, resulting double-stranded cDNA amplicons
optimized for library construction were subjected to
adaptor ligation and sample index PCRs needed for
Illumina bridge amplification and sequencing. Single-
cell libraries were quantified using Qubit (Thermo
Fisher) and quality-controlled using the Bioanalyzer
System (Agilent). Sequencing was performed on a
HiSeq4000 device (Illumina) aiming for 175 mln
reads per library (read1: 26 nucleotides, read2: 64
nucleotides). Data were analysed using CellRanger
v5.0 (10X Genomics) using human and CHIKV gen-
ome scaffolds as described above, and the R packages
Seurat v4.0 [26] and DoRothEA v3.12 [27] were used
for cell clustering, annotation, and transcription factor
activity analysis. Median gene number detected per cell
ranged between 2000 and 4400, with 3800–18500
median UMI counts per cell.
Quantitative RT–PCR
RNA was extracted using the Promega Maxwell 16
with the LEV simplyRNA tissue kit (Promega
AS1270), the Roche MagNAPure with the Cellular
Total RNA Large Volume kit (Roche 05467535001),
or the DirectZol RNA Mini kit (Zymo R2051).
cDNA was prepared using dNTPs (Thermo Fisher
R0181), random hexamers (Jena Bioscience PM-301)
and M-MuLV reverse transcriptase (NEB M0253).
For quantitative RT–PCR, specific Taqman probes
and primers (Thermo Fisher 4331182) were used
with TaqMan Universal PCR Master Mix (Applied
Biosystems 4305719) or LightCycler© 480 Probes
Master (Roche 04887301001). PCRs were performed
on the Applied Biosystems ABI 7500 Fast or the
Roche LightCycler 480 in technical triplicates.
Flow cytometry, confocal and live cell imaging
For flow cytometric analysis of protein expression,
OASF were fixed in 4% PFA (Carl Roth 4235.2), per-
meabilized in 0.1% Triton-X (Invitrogen HFH10)
and immunostained with antibodies against IFIT1
(Origene TA500948, clone OTI3G8), MX1/2 (Santa
Cruz sc-47197), and IFITM3 (Abgent AP1153a) in
combination with Alexa Fluor-647 conjugated anti-
bodies against mouse- (Thermo Fisher A28181), rab-
bit- (Thermo Fisher A27040), or goat-IgG (Thermo
Fisher A-21447). Flow cytometry was performed on
a BD FACSCalibur or FACSLyric and analysed with
FlowJo v10. For immunofluorescence microscopy,
OASF were seeded in 8-well µ-slides (ibidi 80826),
fixed and permeabilized as described above, stained
with antibodies against MXRA8 (biorbyt orb221523)
with AlexaFluor647-conjugated secondary antibody
(Thermo Fisher A28181), and counterstained with
DAPI (Invitrogen D1306). For fluorescence
microscopy and live cell imaging, cells were infected
with CHIKV at an MOI of 10 and imaged with the
Zeiss LSM800 Airyscan Confocal Microscope. Images
were analysed and merged using Zeiss ZEN Blue 3.0.
Immunoblotting
Cell lysates were separated on 10% acrylamide gels by
SDS-PAGE and protein transferred to a 0.45 µm
PVDF membrane (GE Healthcare 15259894) using
the BioRad TransBlot Turbo system. Expression was
detected using primary antibodies detecting MXRA8
(biorbyt orb221523), FHL1 (R&D Systems MAB5938),
IFITM3 (Abgent AP1153a), MX2 (Santa Cruz sc-
47197), ISG15 (Santa Cruz sc-166755), and α-Tubulin
(Cell Signalling Technology 2144S) and appropriate
secondary IRDye antibodies. CHIKV proteins were
detected using anti-CHIKV antiserum (IBT Bioservices
Cat #01-0008 Lot #1703002). Fluorescence was detected
and quantified using the LI-COR Odyssey Fc system.
Measurement of IL-6 and bioactive IFN
Anti-IL-6 ELISA (BioLegend 430504) was performed
according to manufacturer’s protocols. Briefly, plates
were coated with capture antibodies and incubated
with diluted supernatant from CHIKV- or mock-
infected cell cultures. Detection antibody and substrate
were added and the ODmeasured with the Tecan Sun-
rise microplate reader. Concentrations were then cal-
culated the concentration according to a standard
curve measured on the same plate. Bioactive type I
IFN was quantified by incubating supernatant from
CHIKV-infected cells on HL116 cells harbouring a
firefly luciferase gene under the control of an IFN-sen-
sitive promotor. After six h, cells were lysed, incubated
with luciferase substrate solution (Promega E1500),
and luciferase activity was quantified with the BioTek
Synergy HTX microplate reader.
Data and code availability
RNA-seq and single-cell RNA-seq datasets are avail-
able at the NCBI GEO database under the accession
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number GSE152782 and GSE176361, respectively. All
generated code is available at https://github.com/
GoffinetLab/CHIKV_scRNAseq-fibroblast.
Statistics
If not stated otherwise, bars and symbols show the
arithmetic mean of indicated amount of repetitions.
Error bars indicate S.D. from at least three or S.E.M.
from the indicated amount of individual experiments.
Statistical analysis was performed using CLC Work-
bench for RNA-seq and GraphPad Prism 8.3.0 for all
other analysis. Unpaired, two-sided t-tests were
applied with assumed equal standard deviation when
comparing results obtained in the same cell line and
Mann–Whitney-U-tests when comparing between
cell lines or between cell lines and primary cells. For
IC50 calculation, nonlinear fit curves with variable
slopes were calculated. Differentially expressed genes
in RNA-seq data were identified from raw count
data, with calculation of false discovery rate correction
(FDR) p-values for multiple comparisons. P-values for
Gene Ontology analysis were generated after Bonfer-
roni correction for multiple testing. For differential
gene expression analysis from single-cell RNA-seq
data, Wilcoxon rank sum tests with applied Bonfer-
roni correction were applied. Cumulative distri-
butions between groups were compared using the
Kolmogorov–Smirnov (KS) test. Nonparametric
Spearman tests with two-tailed p-values were per-
formed to correlate gene expression. P values <0.05
were considered significant (*), <0.01 very significant
(**), <0.001 highly significant (***); <0.0001 extremely
significant, n.s. = not significant (≥0.05).
Study approval
The local ethic committee (Justus-Liebig-University
Giessen) approved the cooperative study (ethical
vote IDs 66–08 and 74-05). All patients gave written
informed consent prior to inclusion in the study.
Results
Primary human synovial fibroblasts are
susceptible and permissive to CHIKV and MAYV
infection
First, we examined the ability of primary human syno-
vial fibroblasts to support the entire CHIKV and
MAYV replication cycle. Therefore, we infected syno-
vial fibroblasts obtained from osteoarthritic patients
(OASF) and from patients with a non-arthritic back-
ground (HSF) with CHIKV strain LR2006-OPY or
MAYV strain TRVL7546 expressing EGFP under the
control of a second subgenomic promotor. 24 h
post-infection, the proportion of EGFP-positive cells
ranged between 4% and 24.5% for CHIKV and
between 8.5 and 39% for MAYV and did not differ
between fibroblast types (Figure 1(A)). At the same
time point, supernatants of both OASF and HSF dis-
played CHIKV titers of 1.6–8.8 × 105 infectious par-
ticles per ml and MAVV titers of 0.12–2.75 × 105
infection particles per ml, with significantly higher
titers produced by OASF. At 48 h post-infection,
CHIKV titers produced by HSF did not further
increase, whereas the titers produced by OASF
reached up to 1.5 × 107 infectious particles per ml
(Figure 1(B), left panel), suggesting slightly higher
virus production and/or viral spread in OASF as com-
pared to HSF. MAYV titers did not significantly
increase in OASF or HSF at 48 h post-infection
(Figure 1(B), right panel).
Susceptibility of cells to CHIKV infection is
enhanced by the attachment factor MXRA8 [8] and
the cytosolic protein FHL-1 is essential for CHIKV
genome replication [9]. We confirmed expression of
these two cellular cofactors in OASF and HSF by
immunoblotting and/or immunofluorescence (Figure 1
(C)). We assessed the functional relevance of the
MXRA8 attachment factor using a soluble MXRA8-
Fc fusion protein, which blocks the binding site on
the E1-E2 glycoprotein complex on the virus surface
[8]. At a low MOI, MXRA8-Fc-preincubated CHIKV
was 50% less infectious to synovial fibroblasts, and
this inhibition was abolished when saturating amounts
of infectious virus particles were used (Figure 1(D)),
indicating that endogenous MXRA8 contributes, at
least partially, to CHIKV entry in OASF.
Subsequently, we investigated whether IL-1β-
mediated activation of synovial fibroblasts, a hallmark
of rheumatoid arthritis [28], modulates their suscepti-
bility to CHIKV infection. Treatment with IL-1β did
not alter the percentage of EGFP-positive cells upon
CHIKV challenge (Figure S1A), while readily inducing
IL-6 secretion (Figure 1(E)). Conversely, CHIKV infec-
tion induced only low IL-6 secretion and mildly, if at
all, enhanced IL-1β-induced IL-6 secretion (Figure 1
(E)). Overall, these data suggest that IL-6 secretion is
not driven by the infection in a direct manner, but
may be enhanced through external stimuli.
To determine the importance of IFN-mediated anti-
viral immunity in this primary cell system, we analysed
the secretion of type I IFN upon CHIKV and MAYV
infection, which was detectable in cultures infected
with CHIKV and MAYV at an MOI of 10, while
detectable IFN secretion was mostly absent in cultures
infected at an MOI of 1 (Figure S1B). Additionally, we
monitored efficiency of CHIKV and MAYV infection
in the absence or presence of the JAK/STAT inhibitor
Ruxolitinib. Infection efficiency was increased 1.3–4.7-
fold and 1.3–7.7-fold in infected, Ruxolitinib-treated
cells at 24 and 48 h post-infection, respectively, as
compared to mock-treated, infected cultures (Figure 1
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Figure 1. Primary human synovial fibroblasts are susceptible and permissive to CHIKV and MAYV infection. (A) OASF or HSF were
infected with 5′EGFP-CHIKV or -MAYV (MOI 10). 24 h post-infection, the percentage of EGFP-positive cells was quantified by flow
cytometry (n = 3–12). (B) Supernatants of CHIKV- and MAYV-infected OASF or HSF were collected at 24 and 48 h post-infection,
and titers were determined by analysing EGFP expression at 24 h post-infection of HEK293 T cells (n = 3). (C) Uninfected OASF
and HSF were analysed for MXRA8 and FHL1 expression by immunoblotting (n = 4–6) and for MXRA8 expression by immunofluor-
escence. Scale bar = 50 µm (n = 3, representative images shown). (D) OASF were infected with 5′EGFP-CHIKV at the indicated MOIs
upon treatment of the virus with MXRA8-Fc recombinant protein or mock treatment. At 24 h post-infection, cells were analysed for
EGFP expression (n = 4). (E) OASF were stimulated with IL-1β at 10 ng/ml for 16 h and subsequently infected with CHIKV (MOI 10) in
the presence of IL-1β. At 24 and 48 h post-infection supernatant was collected and analysed for IL-6 secretion by ELISA (n = 3). (F)
OASF were infected with 5′EGFP-CHIKV or -MAYV at the indicated MOIs in the presence or absence of 10 µM Ruxolitinib. At 24 and
48 h post-infection, cells were analysed for EGFP expression and (G) for the expression of IFIT1, MX2, and IFNB mRNA. Raw data of
EGFP expression is plotted in Fig. S1C. The dotted line in (F) indicates the relative level of EGFP-positive cells (set to 1) inmock-treated,
individually infected cell cultures. (H) OASF were infected with 5′EGFP-CHIKV (MOI 10) in the presence or absence of 1 or 10 µM
Ruxolitinib or mock-infected. Images were analysed for EGFP intensity using ImageJ (n = 3). Statistical analysis was performed for
A, B, D, and E using two-sided, unpaired t-tests, for F and G using ratio paired t-test with assumed equal standard deviation.
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(F), Figure S1C). In line with the enhanced infection
efficiency, ISG expression was dampened in Ruxoliti-
nib-treated cells, with a significant reduction of IFIT1
expression at 48 h post-infection and a complete sup-
pression of induction of the IFN-dependent gene
MX2 at both time points (Figure 1(G)). Interestingly,
MAYV infection was only mildly enhanced by Ruxoli-
tinib treatment (Figure 1(F)), potentially due to a
higher base-line infection rate (Figure S1C) and a
stronger JAK/STAT-independent induction of IFIT1
by MAYV infection (Figure 1(G)). Using live-cell ima-
ging, we documented the increase in EGFP-positive,
CHIKV-infected cells between ten and 48 h post-infec-
tion, which progressed faster in Ruxolitinib-treated
cultures, with an onset of cytopathic effects observed
after 24 h in all infected cultures (Figure S1D, Suppl.
Mov. 1). Analysis of the EGFP intensity in each
frame over time confirmed the higher expression of
EGFP in Ruxolitinib-treated cultures (Figure 1(H),
Suppl. Mov. 2). Overall, these experiments establish
the susceptibility and permissiveness of synovial fibro-
blasts to CHIKV and MAYV infection and their
expression of important cellular cofactors. Further-
more, we show that the restriction of infection in this
system is, to a large extent, dependent on JAK/
STAT-mediated IFN signalling and secretion, and
demonstrate an absence of interconnection between
IL1-β activation and susceptibility to CHIKV infection.
CHIKV infection provokes a strong cell-intrinsic
immune response in synovial fibroblasts
Next, we performed RNA-seq analysis on OASF and
HSF that had been infected with CHIKV in the pres-
ence or absence of the glycoprotein E2-binding, neutra-
lizing antibody C9 [29], and onmock-infected cells. C9
pre-treatment resulted in potent inhibition of the infec-
tion by on average 16-fold (Figure 2(A)). Upon infec-
tion, expression of numerous IFN-stimulated genes
(ISGs) was induced at the protein level in a C9 treat-
ment-sensitive manner, including IFITM3, ISG15,
and MX2. As expected, production of the viral E1-E2
and capsid proteins was detectable specifically in
CHIKV-infected, but not in cells exposed to C9-pre-
treated virus (Figure 2(B)). Global transcriptional
profiling by RNA-seq revealed 992 (OASF) and 1221
(HSF) upregulated genes as well as 99 (OASF) and
353 (HSF) downregulated genes in CHIKV-infected
cells 24 h post-infection as compared to uninfected
cells (Figure 2(C)). Uninfected cells and cells exposed
to C9-treated virus shared a similar profile (data not
shown). A high similarity of the gene expression
profile of uninfected OASF and HSF (R2 = 0.9086)
argues against a potential transcriptional predisposition
that could have exerted a rheumatoid arthritis-related
gene expression profile or a broad proinflammatory
activation (Figure S2A). Uninfected OASF and HSF
differed in genes involved in organ development and
cellular regulatory processes, and not inflammatory or
antiviral processes (Figure S2B). Additionally, the tran-
scriptional profile in infected OASF and HSF was very
similar (R2 = 0.9085, Figure S2C-D), with an equiva-
lently strong upregulation of a set of prototypic inflam-
mation and arthritis-related genes which we defined for
further analysis (R2 = 0.8202, Figure 2(D)). Interest-
ingly, the number of genes significantly up- and down-
regulated upon infection was 1.23-fold and 3.57-fold
higher in HSF compared to OASF, respectively, but
55.4% of upregulated genes from both groups over-
lapped (Figure 2(E)). Most of the prototypic antiviral
and proinflammatory genes were highly upregulated
in infected cultures, demonstrating a broad and strong
activation of antiviral immune responses in cells from
four different donors with no statistically significant
deviation in the magnitude of induction (Figure 2(F),
left panel). Upregulation of IFNB and IFNL1, IFNL2,
and IFNL3 expression was statistically significant but
low in magnitude, with almost no IFNAmRNA detect-
able. Expression of arthritis-associated genes, including
genes encoding immune cell chemoattractants
(CXCL5, IL8, CD13, RANTES/CCL5), matrix-metallo-
proteases (MMP3, −9, −14, ADAMTS5) and genes
commonly expressed by fibroblasts in rheumatoid
arthritis (FGF2, PDPN, NGF, FAP), was not grossly
altered in CHIKV-infected cells. Exceptions were a
strong CHIKV-induced upregulation of RANTES/
CCL5 in both OASF and HSF and IL8 in HSF (Figure 2
(F), right panel). mRNAs for all IFN receptors were
detectable and stable with exception of IFNLR1,
whose expression was upregulated upon CHIKV infec-
tion (Figure S2E). Established host factors for CHIKV
as well as fibroblast marker genes and cellular house-
keeping genes were not quantitatively altered in their
expression. Virtual absence of expression of mono-
cyte/macrophage lineage-specific genes excluded the
possibility of a contamination of the fibroblast culture
with macrophages, which occasionally has been
reported in early passages of ex vivo-cultured synovial
fibroblasts [22] (Figure S2E). Conclusively, OASF and
HSF share similar basal and CHIKV infection-induced
transcriptional profiles. Overall, CHIKV-infected syno-
vial fibroblasts react to CHIKV infection by extensive
upregulation of antiviral and proinflammatory ISGs.
IFN expression itself was low at 24 h post-infection,
not excluding the possibility that it peaked transiently
at earlier time points.
The CHIKV genome replicates to a high degree
with a bias towards the structural subgenome
We noticed very little inter-donor variation regarding
the distribution of identified viral reads along the viral
genome. The 5´ region of the genome, encoding the
non-structural CHIKV proteins, replicated to a
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Figure 2. CHIKV infection provokes a strong cell-intrinsic immune response in synovial fibroblasts. (A) OASF were infected with
5′EGFP-CHIKV at an MOI of 10 in the presence or absence of the anti-E2 antibody C9 and the percentage of EGFP-positive cells was
measured by flow cytometry (OASF: squares, n = 4; HSF: diamonds, n = 2. The infected samples are marked with their respective
donor number). (B) Selected proteins of cells infected in A were analysed by immunoblotting (n = 4). (C-F) RNA from cells infected
in A was extracted and subjected to RNA-seq (n = 4). Differentially expressed genes were identified by comparison of raw count
data, with calculation of false-discovery rate (FDR) p-value for multiple comparisons. (C) Analysis of up- and downregulated genes
in CHIKV-infected samples compared to mock. Dotted lines indicate cutoff for <1.5 fold regulation and a p-value of >0.05. (D)
Visualization of the fold change induction of indicated genes in CHIKV-infected OASF and HSF. Average fold change (log2) values
for infected OASF are plotted on the x-axis, with corresponding values from infected HSF plotted on the y-axis. R2 value and
regression line for the comparison are inset, dot sizes indicate significance. (E) Overlap of significantly (FDR-p <0.05) up- and
downregulated genes in infected OASF and HSF. Numbers of genes up- or downregulated in either OASF or HSF only, or in
both cell-types, are indicated. (F) Heatmaps of selected gene expression profiles related to innate immune responses (left) or
to secreted proinflammatory mediators and arthritis-connected genes (right) in uninfected or CHIKV-infected cells.
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lower extent than the 3´, 26S subgenomic promoter-
driven, structural protein-encoding genomic region.
Interestingly, this differential abundance of 5´and 3´
reads was also detected in cultures inoculated with
C9-neutralized virus, suggesting infection of a small
number of cells (Figure 3(A)). Overall, the 26S subge-
nomic viral RNA was 5.3-fold more abundant than
nonstructural subgenomes (Figure 3(B)). 18–54%
and 17–44% of the total reads in productively infected
OASF and HSF, respectively, were attributed to the
CHIKV genome (Figure 3(C,D)). In summary, our
analysis revealed efficient replication of the CHIKV
genome in infected fibroblasts with an excess of struc-
tural protein-encoding subgenomic RNA.
Exogenous IFN administration provokes higher
immune responses and leads to improved
protection from infection in primary fibroblasts
than in commonly used cell lines
CHIKV and MAYV infection rates in OASF did not
increase after 24 h post-infection (Figure 4(A)), and
we suspected this to be the result of the strong immune
activation and subsequent IFN signalling. The com-
monly used osteosarcoma cell line U2OS was more
susceptible, while the immortalized fibroblast cell line
HFF-1 displayed reduced susceptibility to alphaviral
infection (Figure 4(A)). OASF exhibited strong induc-
tion of IFIT1 and MX2 CHIKV infection, which
exceeded those mounted by U2OS and HFF-1 cells at
both 24 and 48 h post-infection by 15- to 150-fold.
MAYV infection-provoked ISG responses in OASF
were inferior to those induced by CHIKV, despite
similar percentages of infected cells (Figure 4(B)). Con-
trasting the cell system-specific magnitude of gene
expression upon CHIKV infection, both OASF and
cell lines shared similar responsiveness to 5′-tripho-
sphate dsRNA (5´-ppp-RNA) transfection, which
exclusively stimulates the RNA sensor RIG-I [30], the
main sensor of CHIKV RNA in infected cells [31],
and plasmid DNA transfection (Figure S3A).
Next, we tested the cells´ ability to respond to
exogenous type I and III IFNs, which play a crucial
role in limiting virus infection and protecting the
host [32,33]. We stimulated OASF individually with
a range of IFN-α2 and -λ concentrations at 48 h
prior to infection. At all investigated concentrations,
even at the lowest dose, IFN-α induced a potent upre-
gulation of IFIT1 and MX2 (Figure S3B), and almost
completely inhibited CHIKV infection (Figure 4(C)).
In contrast, IFN-λ induced lower ISG expression levels
(Figure S3B), and inhibited infection less efficiently
(Figure 4(C)). Although less effective than in OASF,
IFN-α restricted CHIKV infection both in U2OS and
HFF-1 cells, while IFN-λ pre-treatment was more
potent in U2OS cells than in OASF, and ineffective
in HFF-1 cells (Figure 4(C)). These antiviral activities
were largely consistent with the respective degree of
ISG expression at the time point of infection (Figure
S3B). IFN-α and -λ induced expression of IFIT1 and
MX2 was higher in U2OS cells than in HFF-1. We
next investigated the sensitivity of CHIKV infection
to IFN when applied four hours post-infection. In
this set-up, IFN-α still displayed a clear, though less
potent antiviral activity when compared to the pre-
treatment setting (Figure 4(D)). In contrast, treatment
of both immortalized cell lines with IFN-α post-infec-
tion was very ineffective (Figure 4(D)).
Interestingly, in all three cells systems, a preceding
CHIKV infection did not antagonize IFN-mediated
induction of ISGs, and led to expression levels of
IFIT1 and MX2 exceeding those induced by IFN-α
alone (Figure S3C). Overall, the data suggest a stron-
ger sensitivity of OASF to IFN-α-induced immunity
compared to commonly used immortalized cell lines.
Most interestingly, and in striking contrast to the
immortalized cell lines, OASF were unique in their
ability to transform a post-infection treatment of
IFN-α into a relatively potent antiviral programme.
Collectively, these data uncover crucial differences
between primary synovial fibroblasts and widely
used immortalized cell lines regarding their cell-
intrinsic innate response to infection and their sensi-
tivity to exogenous IFNs.
Strong immune activation In EGFP protein-
negative and viral RNA-low cells
Finally, we asked how the cell-intrinsic defenses corre-
late with the infection status within individual cells of
a given infected culture by analysing virus-exposed
OASF for their expression of antiviral proteins using
flow cytometry. As expected, expression of IFIT1,
IFITM3 and MX1/2 was enhanced in OASF upon
IFN-α treatment (Figure 5(A)). Interestingly, these
proteins were expressed at even higher levels in
EGFP-negative cells of CHIKV-infected cultures,
while the productively infected, EGFP-positive cells
displayed markedly reduced expression levels of
these factors (Figure 5(A)).
Since absence of EGFP expression does not necess-
arily exclude the presence of viral, potentially abortive
RNA, we performed virus-inclusive single-cell RNA-
seq to establish potential correlations of the quantity
of viral RNA and a specific cellular transcriptional
profile. To this end, we analysed OASF infected at
escalating MOIs. No EGFP-positive cells were detect-
able at six hours post-infection by flow cytometry
(Figure 5(B), left panel). In contrast, 24 h post-infec-
tion, the reporter was expressed in an MOI-dependent
fashion, ranging from virtually 0% to 15% (Figure 5
(B), left panel). IFIT1 and MX2 mRNA expression
was largely proportional to EGFP expression (Figure 5
(B), right panel).
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Single-cell (sc) RNA-seq of the very same cells
showed very little inter-donor variability, and we
merged data from both donors throughout the rest
of the analysis (Figure 5(C)). In order to identify
potential correlations of viral RNA abundance and
the cellular transcription profile, we compared the
Figure 3. The CHIKV genome replicates to a high degree with a bias towards the structural subgenome. (A) NGS reads attributed
to each individual position in the CHIKV genome plotted for synovial fibroblasts infected with CHIKV in the presence or absence of
neutralizing antibody (nAb). SGP: subgenomic promotor. (B) Normalized amount of reads attributed to the structural and non-
structural part of the CHIKV genome in CHIKV-infected OASF and HSF. (C) Number of NGS reads attributed to the human or
CHIKV reference genome in CHIKV or neutralizing antibody-treated CHIKV infected OASF or (D) HSF (n = 4).
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expression of CHIKV RNA to expression of 203 IFN
signalling genes listed in the REACTOME database
(identifier R-HSA-913531, Table 1). For each cell,
the expression of this collection of genes was sum-
marized using Seurat’s AddModuleScore function.
Briefly, this summarizes the expression of a select
group of genes by normalizing the aggregate
expression to a randomly selected, non-overlapping
subset of genes and scores each cell based on its
expression of genes in this module, creating a mod-
ule score (IFN Module Score, IMS). 24 h post-infec-
tion, most identified CHIKV reads corresponded to
the 3′ end of the genome, along with a minor num-
ber of reads mapping to the 3′ end of EGFP, which is
expressed as a subgenomic RNA in infected cells
(Figure S4A). As expected for mock-infected cells,
Figure 4. Exogenous IFN administration provokes higher immune responses and leads to improved protection from infection in
primary fibroblasts than in commonly used cell lines. (A) OASF and HFF-1 cells were infected with 5′EGFP-CHIKV at an MOI of 10,
U2OS cells were infected at an MOI of 0.5. EGFP-positive cells were quantified at 24 and 48 h post-infection by flow cytometry (n =
3-6). (B) Cells infected in (A) were analysed for expression of IFIT1 andMX2mRNA at 24 and 48 h post-infection by quantitative RT-
PCR (n = 3-6). Statistical analysis between samples of the same time point was performed using Mann-Whitney tests. (C) Cells were
treated with IFN-α or -λ for 48 h before infection with 5′EGFP-CHIKV (OASF and HFF-1: MOI 10; U2OS: MOI 0.5) in the continuous
presence of IFN. Inset numbers indicate IC50 values for each time point. (D) Cells were infected with 5′-EGFP CHIKV (OASF and
HFF-1: MOI 10; U2OS: MOI 0.5) and IFN-α was added four hours post-infection. 24 and 48 h post-infection, EGFP-positive cells were
quantified by flow cytometry. Inset numbers indicate IC50 values for each time point. UT: untreated, IU: international units (n = 3
for all experiments). For C and D, nonlinear fit curves with variable slopes for IC50 calculation were used.
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Figure 5. Strong immune activation in EGFP protein-negative and viral RNA-low cells. (A) OASF were infected with 5′EGFP-CHIKV
(MOI 10) or treated with 100 IU/ml IFN-α and immunostained for IFIT1, IFITM3, and MX1/2 24 h post-infection. Numbers in the dot
plots indicate mean fluorescence intensities (MFI) of one representative experiment, and the bar diagram shows quantification of
three individual experiments with statistical analysis by two-sided unpaired t-tests with assumed equal standard deviation (n = 3).
(B) OASF were infected with 5′EGFP-CHIKV at indicated MOIs. Six and 24 h post-infection, EGFP-positive cells were quantified by
flow cytometry (left panel), and cells were analysed for expression of IFIT1 and MX2 mRNA (right panel, n = 6). (C) Using OASF
infected with 5′EGFP-CHIKV, single-cell RNA-sequencing was conducted and UMAP visualizations for sample overlapping after
integration are shown (n = 2). (D) UMAP projections from infected OASF (24 h post-infection) indicate the abundance of
CHIKV 3′ end reads, EGFP 3′ end reads, and IFN signalling gene expression as calculated by IMS (n = 2).
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CHIKV reads were undetectable, and IFN signalling
genes were expressed at basal levels, as calculated by
the IMS. CHIKV RNA abundance per cell increased
in an MOI-dependent manner, however suscepti-
bility to infection was unequally distributed over
individual cells, and a subset of cells displayed a
higher susceptibility than others, as reflected by a
high percentage of reads attributed to the viral gen-
ome (Figure S4B). Strikingly, IFN signalling genes
appeared to be induced predominantly in cells dis-
playing low CHIKV gene expression. Vice versa,
clearly CHIKV RNA-positive cells maintained basal
or reduced expression of IFN signalling related
genes (Figure 5(D)). Of note, six hours post-infec-
tion, CHIKV expression was low and antiviral
responses as presented by the IMS was were largely
absent at low MOIs, while individual ISGs were
induced at higher MOIs (Figure S4C-D). As opposed
to the induction of IFN signalling genes,
known CHIKV cofactors MXRA8, FHL1, and the
fibroblast marker genes VIM and COL3A1 were
broadly and stably expressed under all experimental
conditions. Surprisingly, FURIN, encoding the cellu-
lar protease considered important for viral polypro-
tein cleavage, was detectable only in a minority of
cells (Figure S5).
Correlation analysis of viral and cellular gene
expression reveals a switch from induction to
suppression of transcription factor and ISG
expression
In order to quantify expression of IFN signalling genes
according to viral RNA abundance, we divided cells
into three groups: cells without detectable viral RNA
expression (bystander), cells displaying low amounts
of viral RNA (low) and cells displaying high levels of
viral RNA (high) (Figure 6(A)). Mirroring our initial
observations (Figure 5), we detected a significantly
lower IMS in high cells when compared to low or
bystander cells of the identical culture (Figure S6A).
Six hours post-infection, differential expression of
non-ISGs was very modest between bystander and
viral RNA-positive cells, while it was more pro-
nounced 24 h post-infection (Figure S6B). In contrast,
over 250 ISGs, including ISG15, IFIT1, MX2, IFITM3,
MX1, and IFI6, were upregulated in viral RNA-posi-
tive cells as compared to bystander cells at both inves-
tigated time points. Individual comparisons of either
low or high cells with bystander cells gave similar
overall observations. However, at both investigated
time points, no further upregulation of ISGs was
detected in the high cells as compared to low cells,
but rather a significant downregulation of three ISGs
at 24 h post-infection and six ISGs at six hours post-
infection. This suggests either a loss of cellular tran-
scription activity or a lowered stability of cellular
RNA in cells containing high loads of CHIKV RNA
(Figure S6B).
To increase resolution, we calculated the average
CHIKV and EGFP RNA expression and the average
IMS in bins of 1000 cells for a total of 36 bins,
sorted by their expression level of CHIKV RNA.
At both time points, while the first 7–10 bins rep-
resented cells expressing no or virtually no CHIKV
RNA, the following 18–21 bins represented cells dis-
playing (according to the cut-off defined in Figure 6
(A)) low, but gradually increasing levels of CHIKV
RNA, and largely undetectable EGFP RNA. We con-
sidered the latter cells to represent unproductively
infected cells due to their lack of subgenomic tran-
scripts. The last eight bins displayed cells with over-
all high, starkly increasing levels of CHIKV RNA
and with significant levels of EGFP mRNA. We
hypothesize that these cells represent productively
infected cells. Strikingly, in unproductively infected
cells, IMS values increased proportionally to the
abundance of viral RNA per cell, whereas in produc-
tively infected cells, an inverse proportionality was
observed (Figure 6(B)). This dataset suggests that
expression of IFN signalling genes is upregulated
Table 1. Interferon signalling genes identified by the
REACTOME database.
AAAS HLA-DQA1 IFNGR1 NUP37 STAT1
ABCE1 HLA-DQA2 IFNGR2 NUP42 STAT2
ADAR HLA-DQB1 IP6K2 NUP43 SUMO1
ARIH1 HLA-DQB2 IRF1 NUP50 TPR
B2M HLA-DRA IRF2 NUP54 TRIM10
BST2 HLA-DRB1 IRF3 NUP58 TRIM14
CAMK2A HLA-DRB3 IRF4 NUP62 TRIM17
CAMK2B HLA-DRB4 IRF5 NUP85 TRIM2
CAMK2D HLA-DRB5 IRF6 NUP88 TRIM21
CAMK2G HLA-E IRF7 NUP93 TRIM22
CD44 HLA-F IRF8 NUP98 TRIM25
CIITA HLA-G IRF9 OAS1 TRIM26
DDX58 HLA-H ISG15 OAS2 TRIM29
EGR1 ICAM1 ISG20 OAS3 TRIM3
EIF2AK2 IFI27 JAK1 OASL TRIM31
EIF4A1 IFI30 JAK2 PDE12 TRIM34
EIF4A2 IFI35 KPNA1 PIAS1 TRIM35
EIF4A3 IFI6 KPNA2 PIN1 TRIM38
EIF4E IFIT1 KPNA3 PLCG1 TRIM45
EIF4E2 IFIT2 KPNA4 PML TRIM46
EIF4E3 IFIT3 KPNA5 POM121 TRIM48
EIF4G1 IFITM1 KPNA7 POM121C TRIM5
EIF4G2 IFITM2 KPNB1 PPM1B TRIM6
EIF4G3 IFITM3 MAPK3 PRKCD TRIM62
FCGR1A IFNA1 MID1 PSMB8 TRIM68
FCGR1B IFNA10 MT2A PTAFR TRIM8
FLNA IFNA13 MX1 PTPN1 TYK2
FLNB IFNA14 MX2 PTPN11 UBA52
GBP1 IFNA16 NCAM1 PTPN2 UBA7
GBP2 IFNA17 NDC1 PTPN6 UBB
GBP3 IFNA2 NEDD4 RAE1 UBC
GBP4 IFNA21 NUP107 RANBP2 UBE2E1
GBP5 IFNA4 NUP133 RNASEL UBE2L6
GBP6 IFNA5 NUP153 RPS27A UBE2N
GBP7 IFNA6 NUP155 RSAD2 USP18
HERC5 IFNA7 NUP160 SAMHD1 USP41
HLA-A IFNA8 NUP188 SEC13 VCAM1
HLA-B IFNAR1 NUP205 SEH1L XAF1
HLA-C IFNAR2 NUP210 SOCS1
HLA-DPA1 IFNB1 NUP214 SOCS3
HLA-DPB1 IFNG NUP35 SP100
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in cells harbouring low-to-intermediate levels of viral
RNA, which, however, do not or have not yet pro-
gressed to a productive infection. In contrast, cells
that exceed a certain threshold of viral RNA show
a prevention or downregulation of the expression
of IFN signalling genes. The analysis of expression
of selected genes confirmed this observation.
Expression of individual ISGs, including ISG15,
IFI6, MX1, OASL, IFITs, and IFITMs, and transcrip-
tion factors, including STAT1 and IRF7, was low in
mock-infected and bystander cells, and more pro-
nounced in representative low cells (six hours
post-infection: bin 27–29, 24 h post-infection: bin
26–28) than in high cells (bins 34–36). Furthermore,
expression of genes mediating arthralgia, including
as RANTES, IL1B, IL6, and IL8 was lower in high
cells as compared to low cells (Figure 6(C)). To
identify further putative targets of viral antagonism,
we correlated the expression of all 203 genes of the
IMS to the viral RNA expression in infected cells at
24 h post-infection. We identified 13 genes display-
ing a significant positive correlation (r > 0.3) in the
low CHIKV group, and a significant negative corre-
lation (r <−0.3) in the high CHIKV group (IFITM3,
IFIT3, OAS1, XAF1, GBP1, EIF4A1, EIF2AK2,
STAT1, GBP3, UBC, PSMB8, UBA52). Strikingly,
the only transcription factor present in both groups,
STAT1, was also negatively correlated at six hours
post-infection in the high viral RNA group. We
additionally identified transcription factors JAK1
and IRF7 to switch from weak correlation in the
low CHIKV group to a negative correlation in the
high CHIKV group at 24 h post-infection (Figure 6
(D)). We confirmed this finding using a transcrip-
tion factor activity score analysis using the DoR-
otheEa database, which scores cells based on the
activity of transcription factors inferred from the
expression of the associated target genes in regulons.
The regulon of STAT1 was strongly induced in
bystander and low CHIKV groups at high MOIs,
yet highly susceptible to viral antagonism in the
high CHIKV group. The same observation was
obtained for multiple other transcription factors,
including IRFs and STATs as well as NFκB and c-
JUN, at higher MOIs, indicating a strong and sensi-
tive induction that is counteracted in high cells
(Figure 6(E)). Taken together, our analyses at
single-cell resolution specifically uncovered a spec-
trum of cellular states, displaying a range from
induced to repressed cell-intrinsic immune responses
depending on a threshold abundance of viral RNA
per individual cell. Efficacy of mounting innate
immune responses was highest in cells displaying
low-to-intermediate quantities of viral RNA. Fur-
thermore, viral antagonism manifested itself specifi-
cally in the relatively low percentage of cells
presenting efficient virus replication, consistent
with expression and functionality of virally encoded
IFN antagonists.
Discussion
Given that the joints are the primarily affected body
compartments and that fibroblasts are susceptible to
arthritogenic alphavirus infection in general [6,34],
we hypothesized that cells of the joint synovium are
directly implicated in the pathophysiology of CHIKV-
induced arthralgia. Cells of the synovial tissue and
synovial fluid contain CHIKV RNA and protein upon
CHIKV infection in vivo in humans [5], experimentally
infectedmacaques andmice [7,35]. Additionally, infec-
tious virus was recovered from the joints of infected
macaques at six days post-infection, indicating the
synovium as an active replication site [7]. The main
cell types composing the synovium are macrophages
and fibroblasts. The latter have been identified to be
susceptible to CHIKV infection ex vivo [8]. However,
the corresponding basal innate immune state of pri-
mary synovial fibroblasts and their ability to exert
IFN-mediated antiviral restriction is unknown. Here,
we establish that the widely available OASF and less
available HSF share susceptibility and permissiveness
to CHIKV infection, and describe their basal and infec-
tion-induced transcriptional programmes. We
confirmed that the two cell types share a highly similar
overall transcriptional profile, except in some signalling
pathways unrelated to immunity. CHIKV infection
provoked a striking cellular response that involves
upregulation of multiple ISGs in a JAK/STAT-depen-
dent manner, many of them exerting antiviral activity,
and rheumatoid arthritis-mediating genes. Although
we did not define the PAMP(s) that trigger responses
in synovial macrophages, ISG induction occurred
specifically in cells containing virus genome-, but not
EGFP-specific reads, indicating the absence of de
novo synthesized subgenomic RNA and therefore
suggesting that these cells represent an early or unpro-
ductive infection state. Infection by alphaviruses typi-
cally raises RIG-I-mediated responses through
exposure of dsRNA intermediates and provokes mito-
chondrial DNA leakage that is sensed via cGAS/
STING [31]. Indeed, experimental ligands of both sen-
sors were highly reactive in OASF, as was IFN-α treat-
ment. Surprisingly, also IFN-λ pre-treatment translated
into an antiviral state, indicating that synovial fibro-
blasts may represent an exception to the notion of
otherwise IFN-λ-nonresponsive fibroblasts [36].
Finally, CHIKV infection of synovial fibroblasts was
sensitive to IFN-α applied after inoculation with
virus. These findings appear to contrast with potent
virus-mediated antagonism of IFN in U2OS and
HFF-1 cell lines, which has been suggested to involve
counteraction of nuclear translocation of STAT1 [12].
CHIKV was unable to suppress ISG expression upon
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Figure 6. Correlation analysis of viral and cellular gene expression reveals a switch from induction to suppression of transcription
factor and ISG expression. (A) Visualization of the viral RNA content of infected OASF from Figure 5 at six and 24 h post-infection.
Line indicates the cutoff dividing cells displaying low and high content of viral RNA. Bystander cells were defined as cells with no
detectable viral RNA. (B) Infected OASF were sorted into digital bins of 1000 cells displaying a gradual increase of the amount of
viral reads per cell. Viral reads and the IMS at six and 24 h post-infection are plotted. Coloured bins indicate selected representative
cells for low and high content of viral RNA. (C) Expression of selected genes within mock, bystander, representative low cell bins
(bin 26–29) and high cell bins (bin 34–36) defined in A and B at six and 24 h post-infection. Arrows indicate a statistically signifi-
cant (p < 0.05, fold change >1.5) up- or downregulation (depending on the arrow direction) in low or high CHIKV bins versus
bystander (inside the boxes) or in high CHIKV bins versus low (next to the boxes). Differential gene expression was tested by
Wilcoxon rank sum tests with applied Bonferroni correction. (D) Correlation of CHIKV RNA expression with expression of IFN signal-
ling genes in high and low CHIKV RNA groups calculated by non-parametric Spearman’s test. Transcription factors are plotted in
white, with selected genes in red. (E) Activity of transcription factor regulons within groups defined in A at six and 24 h post-infec-
tion. Arrows indicate a significant up- or downregulation between bystander and low or high CHIKV groups (inside the boxes) or
between low and high CHIKV groups (next to the boxes). Cumulative distributions between groups were compared using non-
parametric Kolmogorov-Smirnov tests.
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exogenous IFN treatment in any cell type, indicating
that the proposed antagonistic functions may not be
strong enough to be detectable at the bulk level. Also,
unaltered levels of expression of housekeeping genes
and genes encoding fibroblast markers in primary
synovial fibroblasts did not generate evidence for a gen-
eral virus-mediated host transcriptional shut-off that
has been reported for several cell lines [13]. Overall,
synovial fibroblasts appear to respond differently to
CHIKV infection as commonly used cell lines. The
underlying reason for this difference is unknown, but
may involve a different intracellular milieu that is
hyper-responsive to CHIKV infection.
While our single-cell RNA-seq approach is based on
3′ end capture and does not allow to discriminate
between full-length and subgenomic viral RNA, we
identified a relative excess of subgenomic RNA in
infected cultures by bulk RNA sequencing, in analogy
to reports for Sindbis virus-infected cells [37].
Enhanced replication of the subgenomic RNA, which
is mediated by the four cleaved nonstructural proteins
forming a replication complex, ensures the rapid pro-
duction of viral structural proteins and the formation
of new virions [38]. While packaging of subgenomic
RNA into virions has been described so far solely for
Aura virus among alphaviruses [39], CHIKV bears a
packaging signal in the nsP2-encoding region of its
genome, selecting specifically full genomic RNA to be
packaged into virions [40]. Therefore, we assume that
the different abundance is based on de novo produced
subgenomic RNA rather than on incoming viral RNA.
Our attempts to identify correlations of cellular
gene expression with CHIKV RNA abundance in indi-
vidual infected cells revealed that a certain threshold of
viral RNA is required to initiate viral RNA sensing and
eventually trigger ISG expression. However, expression
of most ISGs is negatively regulated in the presence of a
high viral RNA burden per cell. This is consistent with
the idea that productive infection involves the syn-
thesis of viral antagonists that hamper the induction
and/or evade the function of ISGs, resulting in efficient
virus propagation. Along these lines, West Nile virus
infection also results in lowered ISG expression levels
in cells harbouring high viral RNA quantities [41]. In
vivo, actively SARS-CoV-2 infected monocytes of
COVID-19 patients expressed lower levels of ISGs
than non-infected bystander cells [42]. Monocytes of
Ebola-infected rhesus monkeys display similar
dynamics, with an additional downregulation of
STAT1 mRNA in infected cells [43]. On the contrary,
cells that undergo abortive infection, or alternatively
have not yet reached sufficient levels of virus replica-
tion fail to mount or repress a strong antiviral
profile. Depending on the longevity of cells harbouring
abortive genomic replication products and intermedi-
ates, their presence may influence the immunopatho-
genesis of chronic aspects of RNA-viral infection.
Owing to genetic recombination and low fidelity of
the alphaviral RNA-dependent polymerase, defective
alphaviral genomes (DVGs) and defective alphaviral
particles arise during virus replication, but are them-
selves replication-incompetent [44]. Of note, our
virus-inclusive sequencing approach does not have
the power to distinguish between full-length viral gen-
omes and defective or otherwise dead-end genomes. It
will be interesting to test the contribution of the latter
to triggering the strong cell-intrinsic innate recog-
nition that we linked here to low intracellular viral
RNA quantities in general. Strikingly, we find indi-
cation that the expression of some genes, such as proi-
nflammatory transcription factors, may be actively
targeted by CHIKV.
Particularly interesting in the context of an a priori
acute RNA virus infection, arthritogenic alphavirus
infection has been suspected to result in the gener-
ation of long-lived cellular reservoirs that may main-
tain low-levels of viral RNA. In mice, fibroblasts
survive a CHIKV infection and joint-associated tissue
can harbour viral RNA in the absence of infectious
virus production for at least 16 weeks [6,45]. Pro-
longed shedding of infectious virus for up to 35
days from ex vivo-infected human synovial fibroblasts
has been observed for Ross River virus (RRV),
another arthritogenic alphavirus [46]. In infected
macaques, infectious CHIKV particles were not
shed for extended periods in the joints, but was
detected in other tissues, including the liver and the
spleen, at 44 days post-infection [7]. In addition to
fibroblasts, other discussed cell types for long-term
persistence are (synovial) macrophages and, to a les-
ser extent, dendritic cells. Macrophages harbour per-
sistent viral RNA in a nonhuman primate infection
model [7] and in human patients, where joint biop-
sies found synovial macrophages to be CHIKV
RNA- and antigen-positive for as long as 18 months
post-infection [5]. In vitro, CHIKV has been pro-
posed to productively infect primary human macro-
phages [34]. Additionally, murine macrophages
have been observed to periodically relapse from
undetectable RRV production to spontaneous or
inducible viral shedding [47]. On the other hand, per-
sistent infection with MAYV has so far only be
observed in RAG-/- mice, suggesting an efficient
clearance of infection by adaptive immune responses
[48]. In the absence of viral proteins antagonizing
host antiviral responses, replication sites in the cyto-
plasm separated by single- or double membranes may
shield the viral RNA from cellular detection and
degradation, as has been demonstrated for flavi-
viruses [49] and coronaviruses [50]. Continuous sen-
sing of viral RNA, which is not necessarily replicated
to a level that would suffice for de novo virus pro-
duction and virus spread, could thereby resonate in
a state of chronic inflammation in the joints of
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infected patients. It is tempting to speculate that
those cell-intrinsic responses that we identified to
be most pronounced in cells displaying low levels of
viral RNA could be identical to those driving the
pain- and inflammation-related joint immunopathol-
ogy linked to chronic alphavirus infection-induced
arthritis. Other suggested mechanisms for alpha-
virus-mediated arthralgia include, similar to Parvo-
virus B19- or Epstein–Barr virus-induced arthralgia
[51,52], the formation of immunogenic autoanti-
bodies through molecular mimicry [53].
Furthermore, human synovial fibroblasts secrete
cytokines such as IL-6, IL1β, and RANTES, stimulat-
ing monocyte migration upon CHIKV infection, and
drive them towards an osteoclast-like phenotype [4].
Interestingly, we identify a similar pattern in infected
fibroblasts with upregulation and/or secretion of IL-6
and RANTES, but not matrix-metalloproteases
(MMPs), as described before [4]. MMP expression
and secretion by synovial fibroblasts can, similar to
IL-6 secretion, be induced through external stimu-
lation with IL-1 and TNF and by activated immune
cells [54]. A paracrine stimulation of MMP expression
by infiltrating immune cells has not been addressed in
this model, but is likely to contribute to the direct
induction of rheumatoid arthritis-like symptoms.
Early IFN-mediated bystander cell activation and
death has been reported in La Crosse virus infected
cultures [55], processes which we do not observe,
suggesting a limited role of bystander cell responses
in this model system. On the other hand, at six
hours post-infection in cultures where we expect
almost all cells to have made contact with virus par-
ticles, we observe a strong activation of the RNA-nega-
tive cells. Additionally, infected synovial fibroblasts
mount an immune response in the absence of JAK/
STAT signalling, although low and without the induc-
tion of the strictly IFN-dependent ISG MX2 in this
model. This indicates that incoming viral RNA in
the absence of a productive infection is sufficient to
trigger pattern-recognition receptors such as RIG-I
in an IFN-independent manner, as shown before
[56], which may lead to the suppression of an active
infection. Nevertheless, IFN-mediated immunity is
majorly responsible for the suppression of viral spread
in infected synovial fibroblasts. While paracrine and
autocrine activation of expression by secreted IFN
would lead to a basic level of immunity in all cells of
the culture, we observed a reduced ISG activation in
highly infected cells, again supporting the hypothesis
that CHIKV actively counteracts JAK/STAT signal-
ling. On the other hand, uninfected bystander cells
were partially ISG-positive, which may protect them
to a certain degree against infection or progression
to highly infected cells. The marginal expression of
IFN genes in most cells in the presented single-cell
RNA-seq dataset indicates that at a given time, only
a small number of cells contribute to the secretion of
IFN, which may explain the overall low amount of
type I IFN detected here.
Finally, an interesting hypothesis foresees that
pharmacological interference with the synovial fibro-
blast-specific hyperreactivity represents a feasible
intervention approach towards the alleviation of
long-term arthralgia. In rheumatoid arthritis, hyperac-
tivated synovial fibroblasts invade the joint matrix,
destroying/disrupting the cartilage and causing long-
term inflammation [57,58]. This and the subsequent
attraction of immune cells, including monocyte-
derived macrophages to the damaged sites, may rep-
resent important events in the progression to long-
term morbidity [59]. Indeed, data obtained in recent
clinical studies suggests that treatment of chikungu-
nya-induced arthritis with the immunosuppressant
methotrexate may be beneficial [60]. The data pre-
sented here support the hypothesis that infected syno-
vial fibroblasts display a phenotype that is reminiscent
of those in rheumatoid arthritis, and that they are a
driver of the typical symptoms in interplay with
infiltrating immune cells. Key features such as the
IL-1β-mediated IL-6 release, the aggressive proinflam-
matory gene expression in productively infected cells,
and the strong expression of important cofactors make
them likely to contribute to viral replication and dis-
ease progression in vivo.
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